Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001840315-23-000006
Filing Date
2023-12-05
Accepted
2023-12-05 08:54:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2930
  Complete submission text file 0001840315-23-000006.txt   4890
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Subject) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-51122 | Film No.: 231465318
SIC: 3826 Laboratory Analytical Instruments

Mailing Address 56F, ONE MUSEUM PLACE 669 XIN ZHA ROAD JING'AN DISTRICT, SHANGHAI F4 200041
Business Address 56F, ONE MUSEUM PLACE 669 XIN ZHA ROAD JING'AN DISTRICT, SHANGHAI F4 200041 862122893688
Ocumension Therapeutics (Reporting) CIK: 0001840315 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144